Clinical Study of Shuangyi Qushi Tongluo Capsules in Treating Knee Osteoarthritis
10.13359/j.cnki.gzxbtcm.2017.02.012
- VernacularTitle:双蚁祛湿通络胶囊治疗膝骨性关节炎的临床研究
- Author:
Weidong LIU
;
Nan LI
;
Qingping LIU
;
Yubao JIANG
;
Changsong LIN
- Keywords:
knee osteoarthritis;
Shuangyi Qushi Tongluo Capsules;
Xianlinggubao Capsules;
bone obstruction
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2017;34(2):196-200
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of Shuangyi Qushi Tongluo Capsules (SQTC) for the treatment of knee osteoarthritis (KOA).Methods A multi-center,randomized,parallel-controlled trial was carried out in 240 cases of KOA patients.The patients were divided into trial group (N =120) and control group (N =120),which was given SQTC,Xianlinggubao capsules respectively for 8 weeks.Before treatment,and 2,4 and 8 weeks after treatment,we recorded the scores of clinical symptoms and traditional Chinese medical syndromes,Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores and knee function scores.After treatment,the clinical efficacy and adverse reaction were observed.Results (1) After treatment for 8 weeks,the clinical efficacy of the trial group was superior to that of the control group (P ＜ 0.05).(2) The trial group had better effect on improving the visual analogue scale (VAS) scores of knee pain,VAS scores of limitation of motion and time for morning stiffness than the control group after treatment for 8 weeks(P ＜ 0.05 or P ＜ 0.01).(3) After treatment for 4 and 8 weeks,the trial group had better effect on improving scores of traditional Chinese medical syndromes,WOMAC scores and Japanese Orthopedic Association(JOA) scores than the control group (P ＜ 0.05 or P ＜ 0.01).(4) Before and after treatment,the results of blood,urine and stool routine examination,liver and kidney function,and electrocardiography showed no significant changes.Conclusion SQTC are effective and safe in treating KOA,and can start an effect shortly.
